Cidara Therapeutics Hosting Key Opinion Leader Meeting on Rezafungin and Cloudbreak Programs

NEXT STORY
Forty Seven Inc. to Report Third Quarter 2019 Financial Results on Tuesday, November 12, 2019
PREV STORY
Apellis Pharmaceuticals Reports Third Quarter 2019 Business Update and Financial Results
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Kevin McCann and Mark Nelson Appointed to the Board of Directors of Telix Pharmaceuticals Limited

MELBOURNE, Australia, Sept. 18, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (“Telix”, the “Company”) ...

author_avatar
NASDAQ Market News

Surface Oncology Announces FDA Fast Track Designation Granted by U.S. Food and Drug Administration for SRF388 to Treat Liver Cancer

author_avatar
NASDAQ Market News

U.S.-Based Psychedelic Healthcare VC Fund, Palo Santo, Appoints New Members to Its Advisory Board, Amid Rapid Growth in Psychedelic Sector

author_avatar
NASDAQ Market News